Neuronetics/$STIM
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Neuronetics
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
Ticker
$STIM
Sector
Primary listing
Employees
658
Headquarters
Website
Neuronetics Metrics
BasicAdvanced
$84m
-
-$0.55
1.13
-
Price and volume
Market cap
$84m
Beta
1.13
52-week high
$4.85
52-week low
$0.80
Average daily volume
2.3m
Financial strength
Current ratio
1.668
Quick ratio
1.035
Long term debt to equity
468.734
Total debt to equity
500.516
Interest coverage (TTM)
-3.31%
Profitability
EBITDA (TTM)
-25.778
Gross margin (TTM)
48.22%
Net profit margin (TTM)
-24.48%
Operating margin (TTM)
-19.14%
Revenue per employee (TTM)
$230,000
Management effectiveness
Return on assets (TTM)
-13.56%
Return on equity (TTM)
-131.56%
Valuation
Price to revenue (TTM)
0.542
Price to book
6.35
Price to tangible book (TTM)
-2.99
Price to free cash flow (TTM)
-6.057
Free cash flow yield (TTM)
-16.51%
Free cash flow per share (TTM)
-0.2
Growth
Revenue change (TTM)
69.52%
Earnings per share change (TTM)
-55.29%
3-year revenue growth (CAGR)
31.58%
3-year earnings per share growth (CAGR)
-26.08%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs